The supplier hasn’t listed a price. We can get their current prices and MOQ.
Verify from $29 · written report in 3 business days · 100% refund if not satisfied
The supplier hasn’t listed a price. We can get their current prices and MOQ.
Verify from $29 · written report in 3 business days · 100% refund if not satisfied
From the supplier
Enoxaparin Sodium
Specification:
Ch.P/EP/USP/IP
Description:
White or off-white powder, odorless and tasteless, highly hygroscopic, easily soluble in water, insoluble in ethanol, ace tone and other organic solvents.
Introduction:
It is a low molecular heparin sodium salt produced with the heparin from the healthy porcine intestinal mucosa, and by alkali depolymerization of the heparin benzyl ester derivative.
Indications:
It has the largest number of indications among all low molecular heparins. It is used for the prevention of venous embolic disease (prevention of intravenous thrombosis), treatment of deep vein thrombosis, and prevention of thrombosis in extracorporeal circulation of hemodialysis. In combination with aspirin, it is effective in treating the unstable angina pectoris and non-Q wave myocardial infarction.
From the supplier
Enoxaparin Sodium
Specification:
Ch.P/EP/USP/IP
Description:
White or off-white powder, odorless and tasteless, highly hygroscopic, easily soluble in water, insoluble in ethanol, ace tone and other organic solvents.
Introduction:
It is a low molecular heparin sodium salt produced with the heparin from the healthy porcine intestinal mucosa, and by alkali depolymerization of the heparin benzyl ester derivative.
Indications:
It has the largest number of indications among all low molecular heparins. It is used for the prevention of venous embolic disease (prevention of intravenous thrombosis), treatment of deep vein thrombosis, and prevention of thrombosis in extracorporeal circulation of hemodialysis. In combination with aspirin, it is effective in treating the unstable angina pectoris and non-Q wave myocardial infarction.
About the supplier
Main products: Medicine
- ✓Exhibited at 10 of the last 10 Canton Fairs
- ✓Foreign Trade Company
- ✓Founded 2010
- ✓1 certificate on file
Health & Recreation exhibitors show in Phase 3 of the Canton Fair, 31 October to 4 November 2026.
- Exhibited at 10 of the last 10 Canton Fairs
- Foreign Trade Company
- Founded 2010
- 1 certificate on file
More from ANHUI MEDIPHARM CO.,LTD.
Similar products from other suppliers
